GGrantIndex
← Leaderboards

Jae K Lee

University Of California, San Diego

$8,143,378
Attributed
$11,092,278
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,092,278 · 8

By mechanism

R01$4,898,854 · 1
RM1$3,654,519 · 1
R21$841,740 · 2
R43$695,052 · 1
R56$523,875 · 1
R41$330,056 · 1

Top collaborators

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Spinal Cord Injury

Research focus

Spinal Cord InjuryInjurySiteIn VivoCicatrixFibroblastsLeadAxon RegenerationNatural RegenerationBehavioralIn VitroCell TypeCellsPathologyAffectGeneticPhenotypePathway InteractionsMyelinSignal TransductionAcuteAxon GrowthNew Therapeutic TargetContusions

Grant awards (27)

Targeting Cell-Type Specific Disease Phenotypes to Promote CNS Repair$1,181,130
RM1 · FY2025 · NS · contact PI
Targeting Lipid Clearance Pathways to Promote Repair after SCI$426,320
R01 · FY2025 · NS · contact PI
Targeting cell-type specific disease phenotypes to promote CNS repair$1,152,811
RM1 · FY2024 · NS · contact PI
Targeting lipid clearance pathways to promote repair after SCI$417,619
R01 · FY2024 · NS · contact PI
Targeting cell-type specific disease phenotypes to promote CNS repair$1,320,578
RM1 · FY2023 · NS · contact PI
Targeting lipid clearance pathways to promote repair after SCI$454,078
R01 · FY2023 · NS · contact PI
Targeting Lipid Clearance Pathways to Promote Repair After SCI$481,767
R01 · FY2021 · NS · contact PI
Regeneration-permissive glia after spinal cord injury$422,125
R21 · FY2021 · NS · contact PI
Targeting lipid clearance pathways to promote repair after SCI$481,767
R01 · FY2020 · NS · contact PI
Targeting lipid clearance pathways to promote repair after SCI$481,810
R01 · FY2019 · NS · contact PI
Assessment of NOVO-118 as a regenerative therapeutic in acute spinal cord injury$347,542
R43 · FY2019 · NS
Targeting lipid clearance pathways to promote repair after SCI$497,115
R01 · FY2018 · NS · contact PI
Assessment of NOVO-118 as a regenerative therapeutic in acute spinal cord injury$347,510
R43 · FY2018 · NS
Targeting lipid clearance pathways to promote repair after SCI$523,875
R56 · FY2017 · NS · contact PI
Role of Fibroblasts in Axon Regeneration after SCI$334,688
R01 · FY2016 · NS · contact PI
Role of Fibroblasts in Axon Regeneration after SCI$334,688
R01 · FY2015 · NS · contact PI
RAP as a therapeutic compound for neuronal regeneration after spinal cord injury$80,122
R41 · FY2015 · NS
Role of Fibroblasts in Axon Regeneration after SCI$331,340
R01 · FY2014 · NS · contact PI
Translational Profile of Perivascular Fibroblasts after Spinal Cord Injury$227,948
R21 · FY2014 · NS · contact PI
RAP as a therapeutic compound for neuronal regeneration after spinal cord injury$224,952
R41 · FY2014 · NS
RAP as a therapeutic compound for neuronal regeneration after spinal cord injury$24,982
R41 · FY2014 · NS
Role of Fibroblasts in Axon Regeneration after SCI$322,974
R01 · FY2013 · NS · contact PI
Translational Profile of Perivascular Fibroblasts after Spinal Cord Injury$191,667
R21 · FY2013 · NS · contact PI
Role of Fibroblasts in Axon Regeneration after SCI$334,688
R01 · FY2012 · NS · contact PI
The role of semaphorins in the injured spinal cord$51,710
F32 · FY2009 · NS · contact PI
The role of semaphorins in the injured spinal cord$49,646
F32 · FY2008 · NS · contact PI
The role of semaphorins in the injured spinal cord$46,826
F32 · FY2007 · NS · contact PI